0001209191-17-002976.txt : 20170109 0001209191-17-002976.hdr.sgml : 20170109 20170109171227 ACCESSION NUMBER: 0001209191-17-002976 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170105 FILED AS OF DATE: 20170109 DATE AS OF CHANGE: 20170109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerulean Pharma Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-996-4300 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eliasof Scott CENTRAL INDEX KEY: 0001688065 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36395 FILM NUMBER: 17518547 MAIL ADDRESS: STREET 1: C/O CERULEAN PHARMA INC. STREET 2: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-05 0 0001401914 Cerulean Pharma Inc. CERU 0001688065 Eliasof Scott C/O CERULEAN PHARMA INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451 0 1 0 0 SVP, Chief Scientific Officer Stock Option (right to buy) 0.82 2017-01-05 4 A 0 60000 0.00 A 2027-01-04 Common Stock 60000 60000 D Stock Option (right to buy) 0.82 2017-01-05 4 A 0 100000 0.00 A 2027-01-04 Common Stock 100000 100000 D This option was granted on January 5, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 1, 2017. This option was granted on January 5, 2017. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of January 1, 2017 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until January 1, 2019. /s/ Alejandra Carvajal, as attorney-in-fact for Scott Eliasof 2017-01-09